EPIDEX
LIVE

Serial Number

79369113

Owner

Healiva SA

Attorney

Barry I. Friedman

Filing Date

Jan 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EPIDEX Trademark

Serial Number: 79369113 • Registration: 7470276

EPIDEX is a trademark filed by Healiva SA on January 9, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Healiva SA (2 trademarks)

Corso Elvezia 4

Entity Type: 99

Trademark Details

Filing Date

January 9, 2023

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Stem cell therapy services; medical services, namely, analysis of human tissues for medical treatment purposes; stem cell bank services for medical transplantation; medical services, namely, the removal, treatment and processing of stem cells; medical services, namely, the removal, treatment and processing of human cells; medical and health care services, namely, DNA screening for medical purposes, genetics counseling and genetic testing for medical purposes; genetic testing for medical use; genetic counseling; regenerative medicine services; medical services in the field of treatment of chronic conditions; medical services in the field of injury healing; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders

Medicines for use in tissue regeneration and wound healing in the management of acute and chronic wounds and rare diseases; enzymes for medical use; pharmaceutical preparations for wound healing in the management of acute and chronic wounds and rare diseases; cells for medical use; living cells for medical use; pharmaceutical preparations containing stem cells for wound healing in the management of acute and chronic wounds and rare diseases; stem cells for medical use; stem cells for veterinary use; transplants being implants comprising living tissue; surgical implants made from living tissues; surgical implants grown from stem cells being living tissue; bone void fillers made from living tissues; tissue-regenerative pharmaceutical preparations; enzymes for veterinary use; all the above mentioned goods not related to the treatment of epilepsy or other neurological disorders

Tissue engineering, namely, genetic engineering of human tissue for others; Analysis of human tissues for medical research; scientific research services, namely, the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of gene therapy; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 5, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 26, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 26, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 19, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 18, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 2, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 16, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 12, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 11, 2023 REPR